Di Caro V, Cho E, North HA, Caldwell J, Pandey K, Duong D, Grundman M, de Haan W, Vijverberg EG, Teunissen CE, Caggiano AO, Seyfried NT, Hamby ME. Identification of cerebrospinal fluid pharmacodynamic biomarkers and molecular correlates of brain activity in a Phase 2 clinical trial of the Alzheimer’s disease drug candidate CT1812. Alzheimers Dement (N Y). 2025 Jun 19;11(2):e70119. doi: 10.1002/trc2.70119. PMID: 40547328; PMCID: PMC12178945.